Opinion|Videos|June 19, 2026 (Updated: June 19, 2026)

The Role of Genetic Counseling and Community Resources in Dravet Syndrome

In “The Role of Genetic Counseling and Community Resources in Dravet Syndrome,” our panel explores the critical role genetic counselors play throughout the genetic testing process and the broader impact of establishing a molecular diagnosis for patients with Dravet syndrome and other genetic epilepsies

In “The Role of Genetic Counseling and Community Resources in Dravet Syndrome,” our panel explores the critical role genetic counselors play throughout the genetic testing process and the broader impact of establishing a molecular diagnosis for patients with Dravet syndrome and other genetic epilepsies. Expert faculty discuss how genetic counselors support clinicians and families before testing through education, informed consent, test selection, and discussions about the potential implications of genetic findings, including incidental findings that may extend beyond epilepsy. The panel also reviews the practical challenges many clinicians face when genetic counselors are not readily available and highlights strategies for integrating genetic testing into clinical practice despite limited resources.

The discussion examines the importance of post-test counseling and interpretation of genetic results, particularly when families are confronted with complex diagnoses or uncertain prognoses. Panelists emphasize that a genetic diagnosis provides benefits that extend beyond treatment selection, including diagnostic closure, improved understanding of disease etiology, and relief from years of uncertainty experienced by many families. Expert faculty explain how identifying the underlying cause of epilepsy allows clinicians to move beyond treating symptoms alone and instead provide patients with a clearer understanding of their condition and future care needs.

Throughout the conversation, the panel highlights how a confirmed genetic diagnosis can connect patients and caregivers with disease-specific advocacy organizations, support networks, educational resources, and clinical research opportunities. Faculty also discuss how genetic diagnoses increasingly enable participation in precision medicine trials and emerging disease-modifying therapeutic programs, reinforcing the growing importance of genetic testing in the long-term management of Dravet syndrome.

Our next episode, “Interpreting Variants of Uncertain Significance in Dravet Syndrome,” expert faculty explore the clinical challenges associated with variants of uncertain significance and their implications for diagnosis and management. The panel discusses approaches to interpreting uncertain findings, the value of ongoing genetic reanalysis, and the importance of multidisciplinary collaboration when evaluating patients with suspected Dravet syndrome.


Latest CME